Results 171 to 180 of about 567,985 (207)
Some of the next articles are maybe not open access.
Dysrhythmias Associated with Digoxin Toxicity
AACN Advanced Critical Care, 1992Digoxin is frequently prescribed for patients. With a narrow therapeutic window, toxicity can quickly occur. Nurses must quickly recognize dysrhythmias associated with digoxin toxicity to prevent life-threatening ...
openaire +2 more sources
Digoxin-specific antibody fragments in the treatment of digoxin toxicity
Clinical Toxicology, 2014Digoxin-specific antibody fragments (digoxin-Fab) are widely regarded as a safe and effective treatment for the management of acute and chronic digoxin poisoning. Calculated equimolar doses of digoxin-Fab are high, very expensive, and infrequently used.To review the pharmacology, efficacy, effectiveness, indications, safety and the dosage of digoxin ...
B S H, Chan, N A, Buckley
openaire +2 more sources
Serum Levels and Digoxin Toxicity
JAMA: The Journal of the American Medical Association, 1981To the Editor.— The otherwise useful review of digitalis in heart failure by Sodums and colleagues (1981;246:158) is flawed by the recommendation that a "maximal effective, yet safe, dose may be attained by measuring serum levels while considering the factors affecting loading and maintenance doses." One should, of course, consider the factors noted ...
openaire +2 more sources
Digoxin toxicity and ritonavir
AIDS, 2003Correspondance
Phillips, E.J., Rachlis, A.R., Ito, S.
openaire +1 more source
Drugs & Aging, 1991
Digoxin is one of the most frequently prescribed drugs, particularly in the elderly population where there is an increased prevalence of atrial fibrillation and cardiac failure. The drug has a narrow therapeutic range and has gained a reputation for producing adverse effects in older patients.
Passmore, A P, Johnston, G D
openaire +2 more sources
Digoxin is one of the most frequently prescribed drugs, particularly in the elderly population where there is an increased prevalence of atrial fibrillation and cardiac failure. The drug has a narrow therapeutic range and has gained a reputation for producing adverse effects in older patients.
Passmore, A P, Johnston, G D
openaire +2 more sources
Clinical Drug Investigation, 2001
To evaluate digoxin pharmacokinetic parameters using Bayesian estimation in 60 patients, and to identify factors that appeared to affect the risk of digoxin toxicity.60 patients with serum digoxin concentrations were evaluated retrospectively. We collected demographic, clinical and laboratory data, and information on concurrent medications and clinical
K, Lecointre +3 more
openaire +2 more sources
To evaluate digoxin pharmacokinetic parameters using Bayesian estimation in 60 patients, and to identify factors that appeared to affect the risk of digoxin toxicity.60 patients with serum digoxin concentrations were evaluated retrospectively. We collected demographic, clinical and laboratory data, and information on concurrent medications and clinical
K, Lecointre +3 more
openaire +2 more sources
Digoxin visual toxicity with therapeutic blood levels of digoxin
American Journal of Ophthalmology, 1998To report two cases of digoxin-related visual disturbances associated with therapeutic blood levels of digoxin.Case reports. One patient reported shimmering lights in the field of vision of both eyes; the second patient had a corrected visual acuity of BE, 20/40 and generalized visual field depression in both eyes.
openaire +2 more sources
Haemoperfusion in the Management of Digoxin Toxicity
Clinical Pharmacokinetics, 1979Several recent publications have encouraged the use of hemoperfusion to remove digoxin from the body of overdosed patients. The usefulness of haemoperfusion in removing digoxin from the body has therefore been examined using pharmacokinetic simulation techniques and published data.
J T, Slattery, J R, Koup
openaire +2 more sources